Keywords: Pharmstandard, Janssen, Johnson & Johnson, Bedaquiline, TB, Russia, Nyuvak, Quisinostat

Pharmstandard to produce Janssen's anti-TB drugs in Russia; Nyuvak deal

Article | 24 January 2013

JSC Pharmstandard (PHST: MM), one of Russia's largest pharmaceutical producers, has signed an agreement with Janssen Pharmaceutica, a subsidiary of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in